A detailed history of Fulcrum Asset Management LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Fulcrum Asset Management LLP holds 29,995 shares of BSX stock, worth $2.57 Million. This represents 4.34% of its overall portfolio holdings.

Number of Shares
29,995
Previous 30,812 2.65%
Holding current value
$2.57 Million
Previous $1.93 Billion 1.99%
% of portfolio
4.34%
Previous 6.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$40.9 - $45.1 $181,964 - $200,649
-4,449 Reduced 30.02%
10,373 $430,000
Q3 2021

Oct 19, 2021

BUY
$41.23 - $45.88 $611,111 - $680,033
14,822 New
14,822 $608,000
Q2 2021

Jul 13, 2021

BUY
$38.58 - $44.24 $0 - $0
0 New
0 $610,000
Q2 2021

Jul 12, 2021

SELL
$38.58 - $44.24 $533,754 - $612,060
-13,835 Closed
0 $610,000
Q1 2021

Apr 21, 2021

BUY
$35.27 - $39.67 $487,960 - $548,834
13,835 New
13,835 $493,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $122B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Fulcrum Asset Management LLP Portfolio

Follow Fulcrum Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Asset Management LLP with notifications on news.